HealthStream Raises 2026 Revenue and Adjusted Earnings Guidance After Third-Quarter Results
Key Facts
HealthStream said results for the third quarter ended September 30, 2026, would be released after the market close on Monday, November 2, according to the company statement setting the release date. The article summary in the news digest says the company announced results and raised its full-year revenue and adjusted EBITDA guidance. However, the available facts here do not include the new figures or details of quarterly performance, so the size of the increase or its connection to revenue and profitability components cannot be determined. After the second quarter, the company had published ranges for its annual outlook, making the announced revision an update to those estimates. Management is scheduled to discuss the results on a call on November 3.
In the second quarter of 2026, HealthStream revenue was about $83.7 million, up 12.5% from $74.4 million in the same period of 2025, according to the earnings statement. Operating income reached $8.3 million, compared with $5.9 million a year earlier, while net income was $6.7 million versus $5.4 million. Adjusted EBITDA was $20.6 million, up 16.9% from $17.6 million in the second quarter of 2025. These figures provide a growth backdrop ahead of the third-quarter results, but do not by themselves show whether the more recent performance maintained the same pace. The comparison shows that second-quarter revenue and profitability growth included improvements in operating metrics and net income.
The company attributed the year-over-year increase in second-quarter revenue to $3.1 million from the acquisitions of Virsys12 and MissionCare Collective, and $6.2 million from growth in its existing solutions portfolio. It said $2.0 million of the existing-portfolio growth was related to a settlement of estimates for variable consideration, distinguishing this portion from recurring growth across solutions. In the first quarter of 2026, revenue had risen 10.5% to $81.2 million, while net income increased 36.4% to $5.9 million compared with the first quarter of 2025. This places the first- and second-quarter results in the context of revenue expansion ahead of the full-year outlook update. The company also announced in September that it had issued new shares for about $40 million in cash to a private investor, and said net proceeds would be used for general purposes, including investment in solutions, working capital and potential acquisitions.
According to the article summary, HealthStream raised its 2026 revenue and adjusted EBITDA guidance. Its estimates published after the second-quarter results put revenue at $327.0–$332.0 million, adjusted EBITDA at $74.0–$78.0 million and net income at $19.5–$22.2 million. The available facts do not include the revised figures, so the range limits cannot be compared or it cannot be determined whether net income guidance changed. In the third quarter of 2025, revenue was $76.5 million and net income was $6.1 million, up 4.6% and 6.3% year over year, respectively. Those results provide a basis for the year-over-year comparison when reading the new figures, without revealing the third-quarter 2026 result on their own.
The company scheduled the start of its third-quarter results call for 9:00 a.m. Eastern Time on Tuesday, November 3, 2026. This is the next announced opportunity for management to detail the results and revised guidance. The company’s shares, HSTM, closed at $33.7 on October 30, according to EL7 data. The facts do not include a share price after the results announcement, so the stock’s response to the announcement cannot be described. Investors will focus on the call for details of the raised guidance and what the company says about net income and the rest of its full-year outlook.